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Systematic development and adjustment of
the German version of the Supportive and
Palliative Care Indicators Tool (SPICT-DE)
Kambiz Afshar1*, Angelika Feichtner2, Kirsty Boyd3, Scott Murray3, Saskia Jünger1,4, Birgitt Wiese1,
Nils Schneider1 and Gabriele Müller-Mundt1
Abstract
Background: The Supportive and Palliative Care Indicators tool (SPICT) supports the identification of patients with
potential palliative care (PC) needs. An Austrian-German expert group translated SPICT into German (SPICT-DE) in
2014. The aim of this study was the systematic development, refinement, and testing of SPICT-DE for its application
in primary care (general practice).
Methods: SPICT-DE was developed by a multiprofessional research team according to the TRAPD model: translation,
review, adjudication, pretesting and documentation. In a pretest, five general practitioners (GPs) rated four case vignettes
of patients with different PC needs. GPs were asked to assess whether each patient might benefit from PC or not (I) based
on their subjective appraisal (“usual practice”) and (II) by using SPICT-DE. After further refinement, two focus groups with 28
GPs (68% with a further qualification in PC) were conducted to test SPICT-DE. Again, participants rated two selected case
vignettes (I) based on their subjective appraisal and (II) by using SPICT-DE. Afterwards, participants reflected the suitability
of SPICT-DE for use in their daily practice routine within the German primary care system. Quantitative data were analysed
with descriptive statistics and non-parametric tests for small samples. Qualitative data were analysed by conventional
content analysis. Focus group discussion was analysed combining formal and conventional content analysis.
Results: Compared to the spontaneous rating of the case vignettes based on subjective appraisal, participants in both the
pretest and the focus groups considered PC more often as being beneficial for the patients described in the case vignettes
when using SPICT-DE. Participants in the focus groups agreed that SPICT-DE includes all relevant indicators necessary for
an adequate clinical identification of patients who might benefit from PC.
Conclusions: SPICT-DE supports the identification of patients who might benefit from PC and seems suitable for routine
application in general practice in Germany. The systematic development, refinement, and testing of SPICT-DE in this study
was successfully completed by using a multiprofessional and participatory approach.
Keywords: Palliative care, General practice, Primary care, Identification tool, SPICT
Background
Prognostic uncertainty forms a major barrier to provid-
ing palliative care (PC) especially in patients with non-
cancer conditions [1–5]. A crucial step to overcome this
barrier is the adequate and timely identification of
primary care patients with potential PC needs [6, 7].
Internationally, there are different tools supporting the
identification of these patients [8–11]. The Supportive
and Palliative Care Indicators tool (SPICT™) is designed
to identify patients with chronic progressive diseases at
risk of deteriorating and who might benefit from a pal-
liative approach. In comparison with other identification
tools, SPICT is not restricted to specific diseases and has
been tested in different settings (e.g. general practice,
care home, hospital) [12–15].
SPICT-DE was the first German version translated and
adapted by a multidisciplinary expert group of clinicians
(physicians and nurses with further qualifications in PC)
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from Austria and Germany in 2014/15. The development
included a backward translation led by Astrid Schnabel
(Germany) and Angelika Feichtner (Austria).
At the beginning of 2015, the Palliative Care Research
Group of the Institute for General Practice at the Hannover
Medical School conducted a first pilot study to assess the
feasibility of SPICT-DE in routine clinical practice [16]. The
prospective, case-control study of patients with cardiovas-
cular or lung diseases was carried out in an internal
medicine ward. The results indicated that SPICT-DE is an
easy-to-use tool supporting the routine identification of
patients with chronic, non-cancer conditions who might
benefit from PC. Furthermore, the feedback of the partici-
pating physicians revealed a need for linguistic adaptation
according to the clinical language culture and style of clin-
ical assessment tools for physicians in Germany.
We thus aimed to further develop, refine and test
SPICT-DE systematically in order to prepare it for ap-
plication in general practice in German-speaking
countries.
Methods
Development, refinement, and testing of SPICT-DE were
conducted systematically in a multidisciplinary team (fam-
ily medicine and PC, public health, psychology, sociology
and nursing sciences) according to the TRAPD model
[17]: translation, review, adjudication, pretesting and
documentation (see Fig. 1).
Structure of SPICT
SPICT comprises three parts: the first section with
general clinical indicators (e.g. poor performance status,
emergency hospital admissions or persistent symptoms),
the second section for condition-specific clinical indicators
(e.g. in cancer, dementia, and cardiac, pulmonary or renal
diseases) and the third section with recommendations for
PC actions (e.g. a conversation about deteriorating health
and dying, advance care planning, a review of care goals with
patients and their relatives, and referral for specialist PC).
Development, structure and evaluation of the original Eng-
lish version of SPICT have been described elsewhere [13].
Translation, review and adjudication of SPICT-DE
Three members of the Palliative Care Research Group of
the Institute for General Practice in Hannover (KA, SJ,
and GMM) reviewed and refined detailed content and
language used in the SPICT-DE several times in close
consultation with the SPICT research team in Edinburgh
and the head of the Austrian-German expert group
(AF). This work formed part of a 5 year review and con-
sensus building approach to SPICT development, refine-
ment and testing led by the SPICT Programme which
Fig. 1 Translation and adjustment of SPICT-DE following the TRAPD model [17]
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has used the SPICT website to access the experiences
and expertise of an online, international community of
over 3000 clinicians and researchers. By combining an
in-depth local consultation with the wider international
consensus, a final agreed version of the SPICT-DE was
adjudicated.
Testing SPICT-DE
The empirical testing of SPICT-DE consisted of two
stages:
1. A pretest with GPs was conducted in autumn 2016 in
order to assess SPICT-DE by rating four different case
vignettes. The feasibility of using SPICT-DE and the
time taken to complete the rating were evaluated.
2. Two professional focus groups with GPs were
conducted in spring 2017 to assess the content and
layout of SPICT-DE from the GPs’ point of view.
The focus groups addressed the following three
goals:
 Probing the handling of SPICT-DE by rating two
exemplary, selected case vignettes.
 Discussing the suitability and feasibility of SPICT-
DE within the German primary care context.
 Evaluating the potential of SPICT-DE in increasing
awareness of patients with potential PC needs
among GPs.
Pretest
Development of case vignettes
Four exemplary case vignettes (A to D) representing
patients with general and/or specialist PC needs were de-
veloped. For a short description of the case vignettes see
Table 1. The four case vignettes were based on qualitative
longitudinal case studies reconstructed from the previous
research project “ELFOP – End of life care for frail older
patients in family practice” (Funding-No.: BMBF
01GY1120) conducted by the Palliative Care Research
Group between 2012 and 2015 [18, 19]. All patients who
took part in that project gave informed written consent
prior to participation [19]. In this study, all four case vi-
gnettes were revised, modified (age, diagnoses, and layout)
and anonymised before testing.
Rating with and without SPICT-DE
A convenience sample of five GPs was recruited from the
research practices of the Institute for General Practice for
participation in the pretest. To ensure a common under-
standing of the term “palliative care”, a German definition
based on the World Health Organisation [20] and the
German Guideline “Palliative care for patients with incur-
able cancer” [21] was given to each participant in hard
copy.
First, the participants were asked to go through the four
case vignettes A to D to assess, based on their subjective
Table 1 Case vignettes A-Da
Case
vignette
Main characteristics and palliative care needs Study part
A • 83-year-old female, widowed, living with her youngest mental
handicapped son at home
• Multiple chronic diseases (e.g. coronary heart disease,
hypertension, morbid obesity, chronic ulcus cruris, polyarthrosis,
discopathy), multiple problems in the activities of daily living,
mobility-impaired
• (General) palliative care indicated
• Pretest
B • 78-year-old female, widowed, living with the family of her
granddaughter at home
• Multiple chronic diseases (e.g. chronic obstructive lung disease,
coronary heart disease with condition after bypass surgery, cardiac
arrhythmias, gastric ulcer with anemia and cachexia), advanced
frailty, mobility-impaired
• (General) palliative care indicated
• Pretest
• Focus groups
C • 76-year-old male, living with his spouse at home
• Multiple chronic diseases (chronic heart failure, hypertension, atrial
fibrillation, osteoporosis, urinary incontinence, polyneuropathy),
multiple problems in the activities of daily and social living,
mobility-impaired, beginning caregiver overload
• Spouse affected by Parkinson’s disease
• (General) palliative care indicated
• Pretest
• Focus groups
D • 65-year-old male, living with his spouse at home
• Non-small-cell lung cancer with cerebellar metastases, several
co-morbidities (e.g. coronary heart disease, cardiac arrhythmias,
condition after stroke, chronic kidney failure, depression), multiple
symptoms (e.g. pain, dyspnea, coughing, dizziness)
• (Specialist) palliative care indicated
• Pretest
aSource: “ELFOP – End of life care for frail older patients in family practice” (Funding: BMBF 01GY1120) [18, 19]
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appraisal, whether each patient might benefit from PC or
not (“usual practice”). Then, they were asked to rate to what
extent the patient’s situation described in each case vignette
seemed to be clear on a 5-point-scale ranging from 1 “not
clear” to 5 “very clear”.
In a second step, the participants were asked to go through
each case vignette once more, this time using SPICT-DE.
They were asked to indicate if the patient under consider-
ation might benefit from PC, when reflecting on the SPICT-
DE indicators. In order to monitor the indicators chosen by
the raters, check boxes were added for each indicator listed
in the SPICT-DE. In addition, participants were asked to
indicate whether there was a change in their appraisal after
using SPICT-DE, and if so, in what way. Participants were
asked to state the total time in minutes needed for reviewing
the case vignettes.
Review of the four case vignettes was supplemented by
two questionnaires: one questionnaire with open-ended
questions to judge the quality of the case vignettes and
the content and language of the revised SPICT-DE, the
other comprising questions about the participant’s basic
sociodemographic data (e.g. sex, age, qualification in PC,
current field of practice, duration of professional experi-
ences). The paper and pencil rating of the case vignettes
was completed anonymised, so that participants’ ratings
of the case vignettes did not identify them individually.
After analysing the results of the pretest and having re-
fined the wording, SPICT-DE was prepared for the sec-
ond phase of testing in the focus groups.
Focus groups
Two members (KA, GMM) of the Palliative Care Re-
search Group of the Institute for General Practice con-
ducted the focus groups in two different quality circles:
focus group A (n = 15) was conducted in February 2017
in Hannover (Germany) and focus group B (n = 13) was
conducted in May 2017 in Achim (Germany). Members
of the two quality circles were family physicians working
in primary care practice.
After receiving information about the aims, content
and format of the study, the chairs of each quality circle
agreed to integrate the testing of SPICT-DE in a forth-
coming meeting. All participants of the focus groups
were informed that their participation would be entirely
voluntary and that they would be free to withdraw from
the group at any time.
A guide for moderating and structuring the focus
groups was developed. Table 2 shows the timeline and
content of the focus group process. After introduction
and ensuring a common understanding of the term “pal-
liative care” (see above) in a short presentation, each
participant of the focus group was asked to write down
Table 2 Timeline and content of the focus groups
Step Action / Assessment Time
I Initiation
• Introduction of participants and research facilitators (KA, GMM)
• Introduction of the project’s objectives/aims and ensuring a common
understanding of the term “palliative care” (short presentation)
• Explanation of intended procedures and clarification of questions
• Informed consent to participate voluntarily and to documentation of the
results of the group discussion
20 min.
II Subjective indicators
• Participants were asked to write down anonymously main criteria and
indicators for the identification of potential PC needs on concept cards
according to their subjective appraisal
10 min.
III Assessment without SPICT-DE (“usual practice”)
• Introduction of case vignettes and explanation of case procession
• Rating of the case vignettes by the participants
20 min.
IV Assessment with SPICT-DE
• Introduction of SPICT-DE and its assessment according to the SPICT
guidelines (https://www.spict.org.uk)
• Rating of the case vignettes by participants using SPICT-DE
• Questionnaires: perception of SPICT-DE, sociodemographic data
• Return of all documents anonymously in a sealed envelope
• Review and clustering of concept cards by the moderators for the
following group discussion simultaneously to case processing
20 min.
V Group discussion
• Participants’ feedback on the case vignettes and case processing
• Participants’ feedback on impression and handling of SPICT-DE
• Discussion of indicators of SPICT-DE by referring to concept cards
• Final discussion of the practicability and potential benefits of
SPICT-DE in the daily practice routine
40 min.
VI Conclusion and outlook 5 min.
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individually on concept cards, what conditions and
aspects would indicate that a patient is in need of PC
according to their subjective appraisal and professional
expertise.
Participants were then asked to go through the two
case vignettes B and C that had proved more difficult to
categorise in the pretest phase to assess, based on their
subjective appraisal, whether each patient might benefit
from PC or not (“usual practice”). They were also asked
to rate to what extent the patient’s situation as described
in each case vignette seemed to be clear on a 5-point-
scale ranging from 1 “not clear” to 5 “very clear”. After
introducing SPICT-DE and its structure, participants
were asked to go through the two case vignettes once
more, but this time using SPCT-DE. They were asked to
indicate if the patient under consideration might benefit
from PC, when reflecting on the SPICT-DE indicators
and whether their opinion had changed as in the pretest
groups.
Feedback, contributions, and results of the group
discussion which followed the individual rating exercise
were documented as part of the focus group work and
recorded by the research facilitators KA and GMM.
Data analysis
As mixed methods were applied in this study, quantita-
tive and qualitative analyses were used. Quantitative data
were analysed with descriptive statistics and non-
parametric tests for small samples (McNemar test and
Mann-Whitney-U test). Statistical analysis was carried
out with the Statistical Package for the Social Sciences
(SPSS) Version 24. Open-ended questions from the sup-
plementary questionnaire were analysed by conventional
content analysis as described by Hsieh and Shannon
[22]. For the focus group discussion a combination of




Participants and sample characteristics
Five GPs (females n = 4, median age 49 years, range 39–54)
participated in the pretest. They had a different degree of
professional experience (median 15 years, range 4–25). One
GP had additional specialist training in Palliative Medicine.
Rating of the case vignettes
The patients’ situations described in the four case vignettes
were rated very heterogeneously by the five GPs. While
case vignette A (median 4, range 1–4) and D (median 5,
range 1–5) appeared to be relatively clear, the case vignettes
B (median 3, range 1–5) and C (median 3, range 2–3) were
considered less clear (scale ranging from 1 “not clear” to 5
“very clear”).
Before using SPICT-DE, a need for PC was identified
for case A by two participants and for case C by one
participant. In case vignette B and D four of the five
participants shared the opinion that both patients might
benefit from PC (see Table 3).
With SPICT-DE to support their reviews, identification
of cases with PC needs changed slightly: in case vignette B
all the GPs now agreed that PC might be indicated and in
case vignette C the number increased from one to three
participants (see Table 3). No participant revised his/her
rating for case vignette A or case vignette D.
Processing time
Participants were asked to note the total time needed for
rating all four case vignettes. The median time for rating
all the case vignettes with and without SPICT-DE was
about 30 min (range 20–45). That meant an average of
7.5 min for each case vignette.
Feedback
Four participants evaluated the case vignettes as distinct
and authentic examples. Furthermore, they made several
suggestions about how to improve the wording and
adapt the layout of the case vignettes. Three of five
participants in the pretest group considered SPICT-DE
as a useful tool to support the decision about whether a
patient might benefit from PC or not. One participant
remarked that a score with a cut-off would make it
easier to assess SPICT-DE. Another participant noted
that SPICT-DE seems to be confusing when using it for
the first time, but that once familiar with the content, it
became easier and clearer to use.
Focus groups
Participants of both groups (n= 28) were GPs. Focus group
A consisted of 15 GPs, who were members of a trans-
regional geriatric quality circle. The majority of the partici-
pating GPs held a further qualification in PC (n = 13/15).
Focus group B consisted of 13 GPs, who were members of a
quality circle and a regional PC network. In contrast to
focus group A, less than half of the participants in focus
group B (n = 6/13) held a further qualification in PC.
Table 3 Pretest rating without and with SPICT-DE (GPs, n = 5)
Case
vignette
“Patient might benefit from palliative care” p-
valuewithout SPICT-DE with SPICT-DE
n (%) n (%)
A 2 (40) 2 (40) n.s.
B 4 (80) 5 (100) n.s.
C 1 (20) 3 (60) n.s.
D 4 (80) 4 (80) n.s.
McNemar-Test compared the groups; p < 0.05; n.s. not significant
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Participants in the two focus groups did not show any
statistically significant differences in their sociodemo-
graphic characteristics except for median age (p = 0.013).
Participants’ characteristics are shown in Table 4.
Assessment with and without SPICT-DE
In both focus groups, participants considered PC more
often as beneficial for the patients described in the case
vignettes when using SPICT-DE. With SPICT-DE, their
initial subjective appraisal of the case vignettes altered.
Table 5 shows the results of the case processing with
and without the assessment being supported by SPICT-
DE. Results of both focus groups are summarised
together.
Without SPICT-DE, 19 participants (68%) saw a need
for PC for the patient in case vignette B. With SPICT-
DE, the number of participants who saw a need for PC
increased to 22 (79%). Without SPICT-DE, five partici-
pants considered that the patient in case vignette C
might benefit from PC. With SPICT-DE, the number of
participants who considered that the patient might
benefit from PC increased significantly to 15 (p = 0.002)
indicating that ten participants revised their first
appraisal.
Over 70% of the participants considered at least one
PC action as recommended in SPICT-DE (e.g. review of
current treatment and medication, communicating
current and future care plan with patients and their fam-
ilies or support of family carers) to be indicated in the
case vignettes (case B: n = 20/28; case C: n = 22/28).
Over half of the participants considered as many as
three PC actions to be indicated in each case vignette
(median 3, range 0–5).
Group discussion
Case vignettes and rating procedures Participants of
both focus groups evaluated the case vignettes as genuine
and authentic examples, reflecting patients seen routinely
in general practice. On a 5-point-scale ranging from 1
“not clear” to 5 “very clear”, about two thirds of partici-
pants considered the presented patient scenario in each
case vignette as clear or even very clear (case vignette B:
median 4, range 2–5; case vignette C: median 4, range 1–
5). Participants stated that the indicators of the SPICT-DE
are more detailed and broadly defined than the subjective
criteria. Especially in ambiguous cases the structured pres-
entation of these objective criteria for PC needs led to an
alteration of the subjective appraisal.
Table 4 Characteristics of participating GPs in the focus groups
Focus group A + B Focus group A Focus group B
n = 28 n = 15 n = 13
Sex (female); n (%) 17 (61) 10 (67) 7 (54)
Age (years); median (range) 55 (38–67)a 57 (42–67)b 45 (38–62)c
Further qualification in PC; n (%) 19 (68) 13 (87) 6 (46)
Professional experience (years); median (range) 24 (10–44) 29 (10–44) 17 (10–40)
Place of Work; n (%)
Single practice 11 (39) 5 (33) 6 (46)
Group practice 16 (57) 9 (60) 7 (54)
Hospital 1 (4) 1 (7) –
an = 24, bn = 13, cn = 11
Table 5 Focus group rating without and with SPICT-DE
Focus group Case vignette “Patient might benefit from palliative care” p-value
without SPICT-DE with SPICT-DE
n (%) n (%)
A (n = 15) Case B 10 (67) 12 (80) n.s.
Case C 3 (20) 7 (47) n.s.
B (n = 13) Case B 9 (69) 10 (77) n.s.
Case C 2 (15) 8 (62) 0.031
A + B (n = 28) Case B 19 (68) 22 (79) n.s.
Case C 5 (18) 15 (54) 0.002
McNemar-Test compared the groups; p < 0.05, significant differences in bold; n.s.: not significant
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Quality and feasibility of SPICT-DE Participants of
both focus groups agreed that SPICT-DE covers relevant
indicators to identify patients who might benefit from
PC. Furthermore, SPICT-DE comprises important rec-
ommendations in providing adequate and timely PC.
By comparing the participants’ individually generated indi-
cators with the indicators in SPICT-DE, we saw that two sets
of indicators were almost identical and differed only in that
the indicators written down on the concept cards were more
detailed and concrete. Group discussion confirmed that the
indicators included in SPICT-DE have good face validity for
practicing GPs in Germany and are sufficiently detailed and
clear to use to support patient identification and prompt
actions for the most important and critical aspects of the
provision of PC. Participants considered the combination of
general and clinical indicators with specific recommenda-
tions for PC actions of the SPICT-DE to be especially helpful
in supporting improved provision of PC for people with
non-cancer illnesses, where the timely identification and
decision-making is often more difficult.
Using SPICT-DE in routine clinical practice In focus
group A, some of the participants said that with SPICT-DE
the number of patients identified in general practice that
might benefit from PC would increase significantly. They
shared the opinion that a considerable proportion of their
population of older patients with multimorbidity could
benefit from PC according to SPICT-DE. Other partici-
pants agreed that SPICT-DE could be helpful in deciding
whether a code for generalist PC according to the German
remuneration system (Einheitlicher Bewertungsmaßstab,
EBM) would be indicated or not. When asked to give an
opinion via the anonymised questionnaires, all the
participants in group A and all but two in group B were
enthusiastic about SPICT-DE and could imagine using it
as part of their daily practice routine to support them in
identifying patients who might benefit from general and/
or specialist PC. One participant, who could not imagine
using SPICT-DE in daily practice routine, stated that the
expression “tool” is confusing and that the SPICT-DE is
nothing but a list of indicators. Furthermore, this partici-
pant was convinced that the gut feeling is an important
aspect itself which cannot be replaced by indicators. An-
other participant was undecided and stated that SPICT-
DE might be too complex for daily practice routine.
Table 6 shows the answers of participants in focus group
B concerning the possible further use of SPICT-DE in
routine clinical practice.
Discussion
In this research paper, we report the results of the first
pilot study on developing and testing the German ver-
sion of SPICT: (1) a pretest with five GPs rating case vi-
gnettes with and without SPICT and (2) focus groups
with 28 GPs to further evaluate and discuss SPICT-DE.
The revision and refinement of SPICT-DE was made ac-
cording to the TRAPD model and in close consultation
with the SPICT research team in Edinburgh and the head
of the Austrian-German expert group. These results pro-
vided the basis for the final multidisciplinary version of
the SPICT-DE 2017, which can be downloaded free of
charge from the SPICT website (http://www.spict.org.uk).
Participants of the focus groups shared the opinion
that SPICT-DE has a great potential to increase aware-
ness for end-of-life issues and support the provision of
advance care planning. This is remarkable as almost two
Table 6 Use of SPICT-DE in daily practice routine (Focus group B)
Code Use of SPICT-DEa Explanation
QZB 01 Yes “Important indicators, which might support the decision-making, especially when added together”
QZB 02 Yes “Supports structured medical history”
QZB 03 Yes “It increased the awareness for advance care planning”
QZB 04 No “For me, the expression “Tool” is misleading; it is simply a list of indicators. I have already used some of
these indicators, whatever remains is the gut feeling”
QZB 05 Yes “So far, decision-making was based on my intuition – a decision-making based on objective criteria is a
reasonable supplement”
QZB 06 Yes “It increases the awareness”
QZB 07 Yes “Reasonable decision aid, especially for case conferences”
QZB 08 Yes “A helpful tool, especially for ambiguous cases”
QZB 09 Yes “It is helpful in cases of uncertainty”
QZB 10 Yes “Supports the decision-making and seeing the big picture”
QZB 11 Yes –
QZB 12 Yes –
QZB 13 Undecided “I don’t know yet, seems to be complex in parts”
aQuestion: “Could you imagine using SPICT-DE in your daily practice routine? Please justify your answer”
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thirds of participating GPs had a further qualification in
PC. Our results promote that especially in ambiguous
cases SPICT-DE might support the identification and
decision-making. There was a significant alteration in
the rating of case vignette C when using SPICT-DE,
especially in focus group B where only 46% of the partic-
ipants had a further qualification in PC. It can be
assumed that using SPICT-DE might be even more
beneficial for those GPs who have no further qualifica-
tions in PC.
There is a controversy in the international literature about
the use of a cut-off value in SPICT. Some authors have con-
sidered whether SPICT could be used as a tool to determine
the prognosis of patients with PC needs and therefore advo-
cated for the necessity of having a cut-off value in SPICT
[15]. However, the current versions of SPICT 2017 and
SPICT-DE 2017 do not include any cut-off value, in line with
increasing recognition that prognostication for individual
people is unreliable and unhelpful in promoting earlier PC
[24]. Identifying people at risk of deteriorating health on the
basis of their clinical situation using SPICT facilitates timely
identification of a broader group of patients who might bene-
fit from PC. Indeed, our study showed that without a cut-off
value, using SPICT-DE led to an increased number of pa-
tients identified with PC needs. In this context, concerns
about potential harm of a cut-off score need to be reflected
in two respects. On the one hand, there may be worries
about deprivation from curative and healing opportunities
among patients meeting the cut-off score. On the other
hand, patients not meeting the cut-off score may be withheld
opportunities of timely addressing end-of-life issues, includ-
ing advance care planning. The identification of these pa-
tients is the prerequisite for initiating a suitable PC
programme, which may involve a critical review of their
medication to avoid polypharmacy and treatments no longer
of benefit, a conversation on end-of-life issues, advance care
planning, a review of care goals with the patients and their
relatives, or simply a prompt to reassess the patient using
SPICT at a later date. The identification process should be
followed by a careful assessment of actual PC needs in the
identified patient.
Our results indicate that the application of SPICT-DE
is feasible in daily clinical practice. The time needed to
apply SPICT-DE in general practice would be less than
in a testing situation, as GPs usually know their patients
better and over time would become more familiar with
the SPICT-DE indicators so able to use them more
rapidly to support patient identification.
Strengths and limitations
The systematic development, refinement, and testing of
SPICT-DE in this study was successfully completed by
using a multiprofessional and participatory approach. In
particular, the involvement of GPs as target group of
potential users in the development process was an
important consideration to increase acceptance of
SPICT-DE before its implementation. A participatory
research approach to refine and develop SPICT has been
adopted from the outset. This approach seems particu-
larly suited for the development of a descriptive tool
designed for use in all care settings and in many
different countries [13].
According to Johanson and Brooks a sample size of
about 30 participants is considered adequate for pilot
studies aiming at scale or tool development [25]. With
28 participants the sample size in this pilot study is close
to these recommendations [25, 26]. A limitation is the
application of case vignettes for the testing of SPICT-
DE. In daily practice the use of the SPICT-DE may be
different. However, the selected case vignettes were con-
sidered as realistic and representative. Another limita-
tion is the gender imbalance in the focus groups as
almost two thirds of participating GPs were females. Al-
though this mismatch was not statistically significant
and did not affect the rating results, potential gender-
specific aspects in the focus group discussions have to
be taken into account.
Conclusions
SPICT-DE is a helpful and practical tool to support the
identification of patients who might benefit from PC.
The introduction of SPICT-DE in the general practice
setting in Germany might change the usual identification
strategy and possibly increase GP’s awareness in provid-
ing PC for patients with different chronic progressive
diseases. The tool may contribute to consolidating skills
and competencies of GPs in identifying patients with po-
tential PC needs and increase their confidence in initiat-
ing PC. The results may also contribute to the overall
improvement and optimisation of primary PC by GPs in
Germany and German-speaking countries. Further re-
search should evaluate the implementation of SPICT-DE
in routine daily practice.
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